Form 4 for CTKB Cytek Biosciences, Inc.
Accepted 2021-07-27 00:00:00 ET · period of report 2021-07-22 · accession 0001209191-21-048387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-27 | 2021-07-22 | CTKB | Dion Gisele | Dir | P - Purchase | $17.00 | +5,000 | 5,000 | New | +$85.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-22 | P | A | 5,000 | $17.00 | 5,000 | D | — | — | (F1) Reflects shares purchased from the underwriters in the Company's initial public offering. |